TickerGuard
Buy Day today: Neutral (54) Mixed market breadth · no major macro event
ELVN

Enliven Therapeutics Inc.

Healthcare · Biotechnology

42.40$ -6.8% vs. previous close Closing price · As of: Oct 6, 2026

Statements

Income Statement

All figures per share in USD.

Tick rows to compare them in a chart (up to 4)

Income Statement ELVN
Line item 2017 2018 2019 2020 2021 2022 2023 2024 2025
– – – 0.00 0.00 0.00 0.00 0.00 0.00
– – 0.01 0.02 0.01 0.10 0.01 0.01 0.00
– – -0.01 -0.02 -0.01 -0.10 -0.01 -0.01 0.00
1.83 1.91 4.40 1.88 2.62 4.96 1.82 1.72 1.52
– 0.56 1.18 0.25 0.55 1.24 0.53 0.51 0.60
2.06 2.47 5.57 2.12 3.17 6.21 2.35 2.22 2.11
-2.06 -2.47 -5.58 -2.12 -3.17 -6.21 -2.35 -2.22 -2.11
– – – – 0.01 0.19 – – –
0.05 -2.62 -5.43 -4.32 -3.17 -6.03 -2.01 -1.89 -1.83
0.05 -0.19 0.15 -0.01 0.00 0.01 0.04 0.00 –
– -2.62 -5.43 -4.32 -3.17 -6.03 -2.01 -1.89 -1.83
0.05 -2.62 -5.42 -2.11 -3.15 -5.99 -2.01 -1.88 -1.83

Data as of: October 6, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?